Suppr超能文献

宫颈癌三维引导下经会阴组织间近距离放疗:技术、局部控制及毒性的系统评价

Three-dimensional-guided perineal-based interstitial brachytherapy in cervical cancer: A systematic review of technique, local control and toxicities.

作者信息

Mendez Lucas C, Weiss Yonatan, D'Souza David, Ravi Ananth, Barbera Lisa, Leung Eric

机构信息

Odette Cancer Centre, Sunnybrook Health Sciences Centre, Department of Radiation Oncology, University of Toronto, Canada.

London Regional Cancer Program, London Health Sciences Centre, Department of Oncology, Western University, Canada.

出版信息

Radiother Oncol. 2017 May;123(2):312-318. doi: 10.1016/j.radonc.2017.03.005. Epub 2017 Mar 25.

Abstract

OBJECTIVE

To evaluate local control and toxicities of perineal-based interstitial brachytherapy (P-ISBT) in cervical cancers treated with three-dimensional (3D) image-based planning through a systematic review. The secondary objective of this review is to summarize the implant and dosimetric techniques in 3D P-ISBT.

METHODS

Systematic review of the literature using the PRISMA guideline was conducted through a search of Medline, EMBASE and Cochrane databases. This search resulted in 19 relevant manuscripts. Selected studies evaluated the role of perineal ISBT in cervical tumours treated using 3D planning. Eleven of nineteen manuscripts contained sufficient information for LC and toxicity calculations. Data were extracted by at least two investigators.

RESULTS

A total of 672 cervical cancer patients were treated with P-ISBT and planned with 3D image-based planning. Clinical outcomes could be identified for 392 patients and 60% were staged IIIB or higher. Most patients received 45-50.4Gy EBRT to the pelvis followed by a P-ISBT boost with a range of dose between 28 and 48Gy EQD. Overall LC was 79% (310/392) with a median follow-up ranging from 14 to 55months. Almost half of the patients (48%) had a median follow-up ≥35months. Patients treated to a lower tumour EQD total dose had inferior LC. Procedure-related complications were rare (7 infections and 7 episodes of bleeding) and limited. Combined late gastro-intestinal, genitourinary and vaginal grade 3 and 4 toxicity was 12.1%.

CONCLUSION

Promising LC rates were found in patients with cervical cancers treated with perineal ISBT with 3D image-based planning. In this systematic review, 60% had stage IIIB disease or higher and yet a LC rate of 79% was found. LC seemed to correlate with the dose delivered to the tumour, while toxicity rates were similar to other cervical cancer series using 3D image-based brachytherapy. Perineal ISBT with 3D planning seems to be an effective and safe treatment for large advanced cervical tumours and may be a reasonable alternative to the increasingly more standard and modern intracavitary/interstitial (IC/IS) approaches such as the 'Vienna' applicator.

摘要

目的

通过系统评价评估基于会阴的组织间近距离放射治疗(P-ISBT)在采用三维(3D)图像引导计划治疗的宫颈癌中的局部控制情况和毒性反应。本评价的次要目的是总结三维P-ISBT中的植入和剂量测定技术。

方法

按照PRISMA指南对文献进行系统评价,通过检索Medline、EMBASE和Cochrane数据库。检索结果得到19篇相关手稿。入选研究评估了会阴组织间近距离放射治疗在采用3D计划治疗的宫颈肿瘤中的作用。19篇手稿中有11篇包含足够的信息用于局部控制率和毒性反应计算。数据由至少两名研究者提取。

结果

共有672例宫颈癌患者接受了P-ISBT治疗,并采用基于3D图像的计划进行规划。可确定392例患者的临床结局,其中60%为IIIB期或更高分期。大多数患者盆腔接受45-50.4Gy的外照射放疗(EBRT),随后进行P-ISBT推量,推量剂量范围为28至48Gy等效剂量(EQD)。总体局部控制率为79%(310/392),中位随访时间为14至55个月。几乎一半的患者(48%)中位随访时间≥35个月。接受较低肿瘤EQD总剂量治疗的患者局部控制率较差。与操作相关的并发症很少见(7例感染和7次出血事件)且程度有限。胃肠道、泌尿生殖系统和阴道联合3级和4级晚期毒性反应发生率为12.1%。

结论

在采用基于3D图像引导计划的会阴组织间近距离放射治疗的宫颈癌患者中发现了有前景的局部控制率。在本系统评价中,60%的患者为IIIB期或更高分期,但局部控制率仍达79%。局部控制似乎与给予肿瘤的剂量相关,而毒性反应发生率与其他采用基于3D图像的近距离放射治疗的宫颈癌系列相似。采用3D计划的会阴组织间近距离放射治疗似乎是治疗大型晚期宫颈肿瘤的一种有效且安全的方法,可能是“维也纳”施源器等越来越标准和现代的腔内/组织间(IC/IS)方法的合理替代方案。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验